Concepedia
Statistics
Publications
9
Citations
440
H-Index
Active since
2008
Affiliations
National Institutes of Health(Current)
Center for Cancer Research
National Cancer Institute
National Institutes of Health Clinical Center
Victoria Luchenko is an author at National Institutes of Health specializing in oncology, medicine, and pharmacology.
Publications per year
2008–2016
MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor
Arup R. Chakraborty, Robert W. Robey, Victoria Luchenko et al. · Blood · 2013 · 87 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +16
Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T‐cell lymphoma
Susan E. Bates, Zhirong Zhan, Kenneth Steadman et al. · British Journal of Haematology · 2009 · 77 citations · Full text
Medicine, Oncology, Pharmacology +15
Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers
Laleh Amiri‐Kordestani, Victoria Luchenko, Cody J. Peer et al. · Clinical Cancer Research · 2013 · 66 citations · Full text
Medicine, Oncology, Pharmacology +17
Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancer
Victoria Luchenko, Crystal D. Salcido, Yongwei Zhang et al. · Cell Cycle · 2011 · 49 citations
Life Sciences, Molecular Biology, Oncology +17
Histone deacetylase inhibitor‐mediated cell death is distinct from its global effect on chromatin
Victoria Luchenko, Thomas Litman, Arup R. Chakraborty et al. · Molecular Oncology · 2014 · 49 citations · Full text
1–5 of 9